Published in Schizophr Res on March 22, 2012
Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry (2013) 1.27
Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr Opin Psychiatry (2014) 1.03
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry (2013) 0.81
Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition. BMC Psychiatry (2014) 0.81
Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers. Transl Psychiatry (2016) 0.81
Evidence for an immune role on cognition in schizophrenia: a systematic review. Curr Neuropharmacol (2014) 0.80
Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain Behav Immun (2016) 0.80
Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia. World Psychiatry (2013) 0.78
Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders. Mol Autism (2014) 0.78
Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study. Int J Neuropsychopharmacol (2014) 0.76
Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients. Oxid Med Cell Longev (2016) 0.75
Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia. Neuroimmunomodulation (2016) 0.75
Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res (2016) 0.75
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75
Targeting the Immune System with Pharmacotherapy in Schizophrenia. Curr Treat Options Psychiatry (2017) 0.75
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J Clin Psychiatry (2012) 3.45
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry (2012) 1.46
Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp (2009) 1.30
New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord (2010) 1.15
The crisis of psychiatry - insights and prospects from evolutionary theory. World Psychiatry (2012) 1.08
Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res (2007) 1.04
Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry (2011) 1.03
Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry (2012) 1.02
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res (2006) 1.01
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (2013) 0.98
Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res (2009) 0.95
Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol Psychiatry (2012) 0.95
An association between plasma ferritin concentrations measured 48 h after delivery and postpartum depression. J Affect Disord (2010) 0.94
Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord (2010) 0.94
Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J Neuroinflammation (2014) 0.93
A long-term physical activity training program increases strength and flexibility, and improves balance in older adults. Rehabil Nurs (2013) 0.92
Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology (2007) 0.92
Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2008) 0.92
Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke (2002) 0.90
Neurocognition in bipolar disorders--a closer look at comorbidities and medications. Eur J Pharmacol (2009) 0.89
Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration. Int J Pharm (2009) 0.88
Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J Clin Psychiatry (2009) 0.86
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophr Res (2012) 0.85
A nationwide study of chronic pain prevalence in the general spanish population: identifying clinical subgroups through cluster analysis. Pain Med (2014) 0.85
Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis. Psychiatry Res (2012) 0.85
Thyroid function 48h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology (2009) 0.85
Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS. Diabetes Metab Res Rev (2011) 0.84
New treatment guidelines for acute bipolar mania: a critical review. J Affect Disord (2011) 0.84
Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology (2012) 0.83
Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res (2012) 0.83
Long-term efficacy of a psychological intervention program for patients with refractory bipolar disorder: a pilot study. Psychiatry Res (2010) 0.83
Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice. Neurosci Lett (2004) 0.83
Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice. Int J Pharm (2011) 0.82
Validation and use of the functioning assessment short test in first psychotic episodes. J Nerv Ment Dis (2010) 0.82
Twin-based study of the complex interplay between childhood maltreatment, socioeconomic status and adult memory. Eur Arch Psychiatry Clin Neurosci (2012) 0.82
Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder. Schizophr Res (2007) 0.81
Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy. J Neurosci Methods (2005) 0.81
Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry (2013) 0.81
The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophr Res (2009) 0.81
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review. J Clin Psychopharmacol (2016) 0.80
Gender differences in outcomes of acute mania: a 12-month follow-up study. Arch Womens Ment Health (2010) 0.80
Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale. J Clin Psychiatry (2010) 0.80
Attitudes of patients and family members towards implantable psychiatric medication. Schizophr Res (2008) 0.80
Effects of conjugated linoleic acid on liver composition and fatty acid oxidation are isomer-dependent in hamster. Nutrition (2005) 0.80
Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol (2004) 0.80
Serotonin transporter gene polymorphism (5-HTTLPR) and emotional response to auditory hallucinations in schizophrenia. Int J Neuropsychopharmacol (2005) 0.80
Are symptom features of depression during pregnancy, the postpartum period and outside the peripartum period distinct? Results from a nationally representative sample using item response theory (IRT). Depress Anxiety (2014) 0.79
Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial. BMC Psychiatry (2014) 0.79
1-year follow-up of patients treated with risperidone and topiramate for a manic episode. J Clin Psychiatry (2003) 0.79
Gene-environment interaction of child temperament. J Dev Behav Pediatr (2010) 0.79
A study of the toxic effect of oxidized sunflower oil containing 4-hydroperoxy-2-nonenal and 4-hydroxy-2-nonenal on cortical TrkA receptor expression in rats. Nutr Neurosci (2009) 0.79
Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.78
[Spanish adaptation of the EAS Temperament Survey for the assessment of child temperament]. Psicothema (2011) 0.78
Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis. Schizophr Bull (2010) 0.78
Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain. Psychopharmacology (Berl) (2004) 0.78
Predictors of recurrence in bipolar disorders in Spain (PREBIS study data). J Affect Disord (2012) 0.78
Manic and depressive symptoms and insight in first episode psychosis. Psychiatry Res (2010) 0.78
Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability. J Clin Psychopharmacol (2013) 0.78
Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder. Bipolar Disord (2010) 0.78
How effective is a psychological intervention program for patients with refractory bipolar disorder? A randomized controlled trial. J Affect Disord (2010) 0.78
Effects of fluoxetine administration on neuropeptide y and orexins in obese zucker rat hypothalamus. Obes Res (2002) 0.77
Obstetric complications as a risk factor for first psychotic episodes in childhood and adolescence. Eur Child Adolesc Psychiatry (2009) 0.77
Heat makes a difference in activity-based anorexia: a translational approach to treatment development in anorexia nervosa. Int J Eat Disord (2010) 0.77
Bipolar disorder differences between genders: special considerations for women. Womens Health (Lond Engl) (2011) 0.77
Septal projections to nucleus incertus in the rat: bidirectional pathways for modulation of hippocampal function. J Comp Neurol (2014) 0.77
Postnatal changes in the nitric oxide system of the rat cerebral cortex after hypoxia during delivery. Brain Res Dev Brain Res (2003) 0.77
Predictors of good outcome in patients with refractory bipolar disorder after a drug or a drug and cognitive-behavioral treatment. Compr Psychiatry (2011) 0.77
MR and genetics in schizophrenia: focus on auditory hallucinations. Eur J Radiol (2008) 0.77
Stress Increases the Negative Effects of Chronic Pain on Hippocampal Neurogenesis. Anesth Analg (2015) 0.76
In vivo effect of tramadol on locus coeruleus neurons is mediated by alpha2-adrenoceptors and modulated by serotonin. Neuropharmacology (2006) 0.76
Brain endocannabinoid system is involved in fluoxetine-induced anorexia. Nutr Neurosci (2008) 0.76
Toluene alters appetite, NPY, and galanin immunostaining in the rat hypothalamus. Neurotoxicol Teratol (2004) 0.76
Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study. Psychiatry Res (2012) 0.76
Eigenanatomy on Fractional Anisotropy Imaging Provides White Matter Anatomical Features Discriminating Between Alzheimer's Disease and Late Onset Bipolar Disorder. Curr Alzheimer Res (2016) 0.76
Fluoxetine alters mu opioid receptor expression in obese Zucker rat extrahypothalamic regions. Int J Neurosci (2006) 0.75
The importance of negative comorbidity. J Clin Psychiatry (2009) 0.75
Antioxidant defense system and family environment in adolescents with family history of psychosis. BMC Psychiatry (2012) 0.75
Adverse drug events in older adults: development of a predictive model. J Am Geriatr Soc (2011) 0.75
Catatonia due to a prion familial disease. Schizophr Res (2009) 0.75
Toluene alters p75NTR expression in the rat brainstem. Ind Health (2004) 0.75
The genetic contribution to first psychotic episodes in children and adolescents of the child and adolescent first-episode psychosis study. Psychiatr Genet (2008) 0.75
Activation of extracellular signal-regulated kinases (ERK 1/2) in the Locus Coeruleus contributes to pain-related anxiety in arthritic male rats. Int J Neuropsychopharmacol (2017) 0.75
Inflammatory activation and cholinergic anti-inflammatory system in eating disorders. Brain Behav Immun (2013) 0.75
Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight. Nutr Neurosci (2002) 0.75
Development of the insight scale for affective disorders (ISAD): modification from the scale to assess unawareness of mental disorder. J Affect Disord (2012) 0.75
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients. J Clin Psychopharmacol (2017) 0.75
Serotonin transporter gene polymorphisms and auditory hallucinations in psychosis. Rev Neurol (2010) 0.75
Spanish version of the Link's Perceived Devaluation and Discrimination scale. Psicothema (2016) 0.75
[TNF and cytokines and pain: Beyond the tisular inflammation]. Reumatol Clin (2009) 0.75
Effects of fluoxetine administration on regional galanin expression in obese Zucker rat hypothalamus. Nutr Neurosci (2004) 0.75